glp 1 cause kidney issues Uncovering hidden opportunities in the GLP-1 era GLP-1 Receptor Agonists and Kidney

One of the most common side effects we see with ozempic is GI distress due to slowed gut motility

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

Progression of tubulointerstitial fibrosis and the chronic kidney disease phenotypeRole of risk factors and epigenetics

The ozempic comparison: Where it comes from Evidence review: Berberine for weight loss and metabolic health Regulatory and safety concerns What do experts say

Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside